Literature DB >> 12788837

The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.

Paresh Dandona1, Ahmad Aljada, Ajay Chaudhuri, Arindam Bandyopadhyay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12788837     DOI： 10.1210/jc.2003-030178

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  33 in total

Review 1.  Inflammatory lipid mediators in adipocyte function and obesity.

Authors:  Abishek Iyer; David P Fairlie; Johannes B Prins; Bruce D Hammock; Lindsay Brown
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

Review 2.  The essential role of exercise in the management of type 2 diabetes.

Authors:  John P Kirwan; Jessica Sacks; Stephan Nieuwoudt
Journal:  Cleve Clin J Med       Date:  2017-07       Impact factor: 2.321

3.  Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.

Authors:  S Mirza; Monir Hossain; Christine Mathews; Perla Martinez; Paula Pino; Jennifer L Gay; Anne Rentfro; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Cytokine       Date:  2011-10-28       Impact factor: 3.861

4.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

5.  Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?

Authors:  Greet Van den Berghe
Journal:  Crit Care       Date:  2010-02-16       Impact factor: 9.097

6.  Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells.

Authors:  Evren Caglayan; Giulio R Romeo; Kai Kappert; Margarete Odenthal; Michael Südkamp; Simon C Body; Stanton K Shernan; Daniel Hackbusch; Marius Vantler; Andrius Kazlauskas; Stephan Rosenkranz
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

7.  The multifaceted role of profilin-1 in adipose tissue inflammation and glucose homeostasis.

Authors:  Munkyong Pae; Giulio R Romeo
Journal:  Adipocyte       Date:  2013-11-05       Impact factor: 4.534

8.  Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Authors:  Angela M Whetzel; David T Bolick; Catherine C Hedrick
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

9.  Insulin reduces plasma arginase activity in type 2 diabetic patients.

Authors:  Sangeeta R Kashyap; Abigail Lara; Renliang Zhang; Young Mi Park; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2007-10-10       Impact factor: 19.112

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.